J9063 — Mirvetuximab Soravtansine-gynx 5 Mg/ml Intravenous Solution
$27,697
All-payer median here
$31,063
Cash / self-pay here
1
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.